Arbutus Biopharma Corp · Stock-Based Compensation

Latest reported$5.51Mperiod endingJun 30, 2026

ABUS Stock-Based Comp ($0.00 → $5.51M)

Annual stock-based compensation

High-resolution chart · PNG

ABUS stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	6,953,000
Dec 31, 2024	8,986,000
Dec 31, 2023	9,301,000
Dec 31, 2022	7,182,000
Dec 31, 2021	6,424,000
Dec 31, 2020	6,161,000
Dec 31, 2019	6,799,000
Dec 31, 2018	6,241,000
Dec 31, 2017	15,117,000
Dec 31, 2016	39,159,000
Dec 31, 2015	22,093,000
Dec 31, 2014	3,283,000
Dec 31, 2013	903,005
Dec 31, 2012	986,757
Dec 31, 2011	613,240
Dec 31, 2010	650,515
Dec 31, 2009	253,734
Dec 31, 2008	0
Dec 31, 2007	380,279
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0